![Dennis Purcell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis Purcell
Président chez
SOLVONIS THERAPEUTICS PLC
Fortune : 134 334 $ au 31/05/2026
Profil
Dennis Joseph Purcell is the founder of Aisling Capital LLC, serving as Senior Advisor since 1998.
Current jobs include Chairman at Solvonis Therapeutics Plc since 2024, Director at Rosetta Capital Ltd. since 2017, Director at Real Endpoints LLC, Independent Director and Advisor at Bioscience Managers Pty Ltd. since 2003, Chief Operating Officer & Director at Summus Global, Inc., Non-Executive Director at Ichnos Glenmark Innovation, Inc., Director at ViralClear Pharmaceuticals, Inc. since 2020, and Advisor at The New York City Investment Fund Manager, Inc. Former jobs include Special Advisor to the CEO at Awakn Life Sciences Corp., Executive Chairman at Poliwogg Holdings, Inc., Director at Valentis, Inc., Director at Paratek Pharmaceuticals, Inc. from 2009 to 2012, Director at Cengent Therapeutics, Inc., Director at Bridge Pharmaceuticals, Inc., Director at Biotechnology Innovation Organization, Director at Embera NeuroTherapeutics, Inc., Director at Dynova Laboratories, Inc., Managing Director at PaineWebber, Inc., Director at Aton Pharma, Inc., Managing Director at Chase H&Q from 1995 to 1998, Director at Xanodyne Pharmaceuticals, Inc., Director at New York Biotechnology Association, Inc., Director at The Irvington Institute for Immunological Research, and Member at Harvard Medical School.
Education includes an MBA from Harvard University and an undergraduate degree from the University of Delaware.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/05/2025 | 39 861 638 ( 0,59% ) | 134 334 $ | 31/05/2026 |
Postes actifs de Dennis Purcell
| Sociétés | Poste | Début |
|---|---|---|
| SOLVONIS THERAPEUTICS PLC | Président | 26/09/2024 |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Fondateur | 01/01/1998 |
The New York City Investment Fund Manager, Inc.
 The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager invests in the companies located in the United States. The firm focuses on fintech, health IT, life sciences and advanced manufacturing sectors. It participates in early and growth stage capital transactions. The firm acquires minority interest. | Consultant / Advisor | - |
Real Endpoints LLC
 Real Endpoints LLC Data Processing ServicesTechnology Services Provides information and analytics services | Directeur/Membre du Conseil | - |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Directeur/Membre du Conseil | 01/01/2003 |
Summus Global, Inc.
 Summus Global, Inc. Internet Software/ServicesTechnology Services Operates as virtual healthcare platform | Directeur des opérations | - |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Directeur/Membre du Conseil | - |
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to fight SARS-CoV-2 virus that causes COVID-19 | Directeur/Membre du Conseil | 28/05/2020 |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Private Equity Investor | 30/10/2017 |
Anciens postes connus de Dennis Purcell
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Dennis Purcell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
27
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 27 |
|---|---|
Valentis, Inc.
 Valentis, Inc. Pharmaceuticals: MajorHealth Technology Develops products for urology indications | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative solutions for patients with infectious diseases | Health Technology |
Cengent Therapeutics, Inc.
 Cengent Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches & develops pharmaceutical drugs | Commercial Services |
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Finance |
Bridge Pharmaceuticals, Inc.
 Bridge Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research services to the pharmaceutical industry | Commercial Services |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Embera NeuroTherapeutics, Inc.
 Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for smoking cessation, cocaine dependence and other addictions | Health Technology |
Dynova Laboratories, Inc.
 Dynova Laboratories, Inc. Food RetailRetail Trade Develops and markets natural healthcare products and supplements | Retail Trade |
Poliwogg Holdings, Inc.
 Poliwogg Holdings, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PaineWebber, Inc.
 PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Finance |
Aton Pharma, Inc.
 Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical therapeutics for cancer and other diseases | Health Technology |
Chase H&Q
 Chase H&Q Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xanodyne Pharmaceuticals, Inc.
 Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
The New York City Investment Fund Manager, Inc.
The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager invests in the companies located in the United States. The firm focuses on fintech, health IT, life sciences and advanced manufacturing sectors. It participates in early and growth stage capital transactions. The firm acquires minority interest. | Finance |
Rosetta Capital Ltd.
Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Finance |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
The Irvington Institute for Immunological Research
 The Irvington Institute for Immunological Research Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Real Endpoints LLC
Real Endpoints LLC Data Processing ServicesTechnology Services Provides information and analytics services | Technology Services |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Summus Global, Inc.
Summus Global, Inc. Internet Software/ServicesTechnology Services Operates as virtual healthcare platform | Technology Services |
Graft Polymer (UK) Plc
 Graft Polymer (UK) Plc Miscellaneous ManufacturingProducer Manufacturing Develops polymer modification technologies | Producer Manufacturing |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to fight SARS-CoV-2 virus that causes COVID-19 | Health Technology |
Awakn Life Sciences Corp.
 Awakn Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides psychedelic assisted psychotherapy solutions | Health Services |
